MAP4K4 inhibition promotes survival of human stem cell-derived cardiomyocytes and reduces infarct size in vivo
Main Author: | |
---|---|
Format: | Journal article |
Published: |
Elsevier
2019
|
Summary: |
---|
Main Author: | |
---|---|
Format: | Journal article |
Published: |
Elsevier
2019
|
Summary: |
---|